Heart disease is a leading cause of death worldwide, in part due to an increased risk for atrial fibrillation and ventricular tachyarrhythmias. These lethal arrhythmias can be triggered by acute electrophysiological fluctuations driven by acute (patho-)physiological fluctuations in the heart’s mechanical load (‘mechano-arrhythmogenesis’). If these acute electrophysiological interact with persistent, structure-function alterations in cell-level (e.g., ion channel activity, cytoskeletal elements, or oxidative state) or tissue-level (e.g., cellular connectivity or fibrosis) factors, they can result in sustained arrhythmias. Yet, the underlying mechanisms of mechano-arrhythmogenesis are generally unknown. The goal of this project is to define the mechanisms and importance of atrial and ventricular mechano-arrhythmogenesis in various forms of heart disease. Experiments are carried out in rabbit isolated cells, tissue, and whole hearts - as well as human patient cells and tissue - with controlled alterations of mechanical load, functional fluorescence imaging, video-based mechanical measurements, microelectrode and patch-clamp recordings, immunofluorescent and molecular assessments, and targeted pharmacological interventions. Ultimately, this work which will provide crucial insight into the mechanisms and importance of mechano-arrhythmogenesis and identify potential novel anti-arrhythmic targets for its prevention.